Pouch or True “Ouch”?- Avoid Common Mistakes in the Diagnosis and Management of Ileal Pouch Disorders

Content Type: presentation

Presenter: Speaker: Bo Shen, MD; Moderator: David T. Rubin, MD, FACG

Presenter Disclosure: Bo Shen, MD : Consultant for Janssen, AbbVie, and Takeda; Speaker for AbbVie and Takeda; David T. Rubin, MD, FACG : Advisory Committee/Board Member: CCFA, Janssen Consultant: AbbVie Pharmaceuticals, Abgenomics, Allergan, Biomica, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Check-cap, Dizal Pharmaceuticals, Galen Pharma/Atlantica, Genentech, Gilead Sciences, Ichnos Sciences S.A. (formerly Glenmark Pharmaceuticals), GSK, Janssen, Lilly, Narrow River Mgmt., Pfizer, Prometheus, Reistone, Shire, Takeda, Techlab, Inc.; Grant/Research Support: AbbVie Pharmaceuticals, Genentech, Janssen, Prometheus Laboratories, Shire, Takeda; Co-Founder: Cornerstones Health Inc. (non-profit medical education company), GoDuRn LLC (no financial support received); Royalties: Slack Publications

Event: ACG Virtual Grand Rounds

Release Date: 10/23/2020

Expiration Date: 10/23/2023

Objective: 1. To recognize common structural, inflammatory, and functional disorders of the ileal pouch.2. To be familiar with the use of proper diagnostic modalities3. To be familiar with current medical treatment regimen for pouchitis, Crohn�s disease of the pouch, and cuffitis4. To be familiar with endoscopic treatment of structural disorders of the pouch, such as strictures, presacral abscess, and prolapse